These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21517761)

  • 1. Ankylosing spondylitis, late osteoarthritis, vascular calcification, chondrocalcinosis and pseudo gout: toward a possible drug therapy.
    Mebarek S; Hamade E; Thouverey C; Bandorowicz-Pikula J; Pikula S; Magne D; Buchet R
    Curr Med Chem; 2011; 18(14):2196-203. PubMed ID: 21517761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician.
    Pay S; Terkeltaub R
    Curr Rheumatol Rep; 2003 Jun; 5(3):235-43. PubMed ID: 12744817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium pyrophosphate deposition disease: clinical manifestations.
    Ferrone C; Andracco R; Cimmino MA
    Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease.
    So PP; Tsui FW; Vieth R; Tupy JH; Pritzker KP
    J Rheumatol; 2007 Jun; 34(6):1313-22. PubMed ID: 17516619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience.
    Pascart T; Norberciak L; Legrand J; Becce F; Budzik JF
    Osteoarthritis Cartilage; 2019 Sep; 27(9):1309-1314. PubMed ID: 31146015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
    Whelan MG; Hayashi K; Altwies H; Tedeschi SK
    J Rheumatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 37061233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP
    J Rheumatol; 1983 Oct; 10(5):769-77. PubMed ID: 6315937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
    Hirose J; Ryan LM; Masuda I
    Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dentin Matrix Protein 1 Regulates Mineralization of MC3T3-E1 Cells via the TNAP-ANK-ENPP1 Axis.
    Liu J; Zhao J; Li Z; Wang H; Wang B; Liu W; Zhou L
    J Nippon Med Sch; 2023; 90(3):262-271. PubMed ID: 37380477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of thiophenyl derivatives as inhibitors of alkaline phosphatase.
    Chang L; Duy do L; Mébarek S; Popowycz F; Pellet-Rostaing S; Lemaire M; Buchet R
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2297-301. PubMed ID: 21421310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage.
    Johnson K; Terkeltaub R
    Front Biosci; 2005 Jan; 10():988-97. PubMed ID: 15569637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles.
    Thouverey C; Bechkoff G; Pikula S; Buchet R
    Osteoarthritis Cartilage; 2009 Jan; 17(1):64-72. PubMed ID: 18603452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium pyrophosphate dihydrate crystal induced arthropathy].
    Announ N; Guerne PA
    Rev Med Suisse; 2007 Mar; 3(103):740-2, 744, 746. PubMed ID: 17458152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug.
    Danino O; Svetitsky S; Kenigsberg S; Levin A; Journo S; Gold A; Drexler M; Snir N; Elkayam O; Fischer B; Arad U
    Rheumatology (Oxford); 2018 Aug; 57(8):1472-1480. PubMed ID: 29688536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cartilage icing and chondrocalcinosis on knee radiographs in the differentiation between gout and calcium pyrophosphate deposition.
    Falkowski AL; Jacobson JA; Kalia V; Meyer NB; Gandikota G; Yosef M; Thiele RG
    PLoS One; 2020; 15(4):e0231508. PubMed ID: 32298308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.
    Uzuki M; Sawai T; Ryan LM; Rosenthal AK; Masuda I
    J Rheumatol; 2014 Jan; 41(1):65-74. PubMed ID: 24293574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondrocalcinosis and other calcifications.
    Jensen PS
    Radiol Clin North Am; 1988 Nov; 26(6):1315-25. PubMed ID: 2845468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.
    Camerlain M; McCarty DJ; Silcox DC; Jung A
    J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of calcium crystals in OA knees.
    Fuerst M; Lammers L; Schäfer F; Niggemeyer O; Steinhagen J; Lohmann CH; Rüther W
    Rheumatol Int; 2010 Mar; 30(5):623-31. PubMed ID: 19639325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium crystal-associated arthritides.
    Rosenthal AK
    Curr Opin Rheumatol; 1998 May; 10(3):273-7. PubMed ID: 9608333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.